Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis

Parnian Shobeiri; Sanam Alilou; Mehran Jaberinezhad; Farshad Zare; Nastaran Karimi; Saba Maleki; Antônio Lúcio Teixeira; George Perry; Nima Rezaei

doi:10.1371/journal.pone.0281784

Related publications

Article2022

Role of non‑coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)

Katerina Pierouli, Eleni Papakonstantinou, Louis Papageorgiou, Io Diakou, Τhanasis Mitsis, Konstantina Dragoumani, Demetrios�� Spandidos, Flora Bacopoulou, George Chrousos, George N. Goulielmos, Elias Eliopoulos, Dimitriοs Vlachakis

Article2008

Antibody‐Antigen Dissociation: A Novel Diagnostic Tool in Alzheimer Disease

Mark A. Smith, Kasia Gustaw, Matthew R. Garrett, Sandra L. Siedlak, Xiongwei Zhu, Robert P. Friedland, Hyoung‐gon Lee, George Perry

Article2021

Two long non-coding RNAs, CAT179 and CAT 1796, differentiate between benign prostate hyperplasia and prostate cancer

Nasim Ebrahimi, Farzane Amirmahani, Maryam Akbari, Ghahfarokhi Mosharaf, Bahareh Hajihashemi, Michael R Hamblin

Article2018

Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer?

David Hanly, Manel Esteller, María Berdasco

Article2010

Biomarkers in Alzheimer's Disease: Past, Present and Future

Katarzyna Gustaw‐Rothenberg, Alan J. Lerner, David Bonda, Hyoung‐gon Lee, Xiongwei Zhu, George Perry, Mark A. Smith